Today, the first of 120 patients to be recruited to TenoMiR’s Phase 2 study, which is testing CWT-001’s safety and efficacy in treating Tennis elbow (lateral epicondylitis). The multi-site clinical trial includes sites in the UK, The Netherlands, and the US.